Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Cellectis/2Blades cross-license TAL technologies

French genomics company Cellectis' US subsidiary, Cellectis Plant Sciences (New Brighton, Minnesota), and the US charitable group, the Two Blades Foundation (2Blades - Evanston, Illinois), have entered into a non-exclusive cross-licensing agreement covering TAL (transcription activator like) nuclease technologies. 2Blades receives a licence to Cellectis' TALEN (transcription activator like effector nucleases) technology for non-profit uses, including efforts to support subsistence farming and certain commercial applications related to disease management programmes. Cellectis gains a licence to 2Blades' TAL Code technology related to nucleases for commercial uses in certain specified crops, with an option to extend the deal to additional crops. TAL technologies target genes at precise sites and enable specific regulation of gene expression.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts